Glucose tolerance in patients with cystic fibrosis: five year prospective study.
about
Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)A Practical Approach to Glucose Abnormalities in Cystic FibrosisDiabetes in cystic fibrosis: multicenter screening results based on current guidelinesInsulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study.Early glucose abnormalities in cystic fibrosis are preceded by poor weight gain.Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine SocietyDiagnosis, screening, and management of cystic fibrosis-related diabetes.Management of cystic fibrosis-related diabetes in adolescence.Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.Cystic fibrosis-related diabetes.Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.How has research in the last five years changed my clinical practice?Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.Renal involvement in cystic fibrosis: diseases spectrum and clinical relevanceGenetic modifiers play a substantial role in diabetes complicating cystic fibrosis.Management of diabetic ketoacidosis in children and adolescents.Management of cystic fibrosis-related diabetes.Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.Symposium 6: Young people, artificial nutrition and transitional care. The nutritional challenges of the young adult with cystic fibrosis: transition.Management of cystic fibrosis-related diabetes in children and adolescents.Cystic fibrosis-related diabetes in children--gaps in the evidence?Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.Malnutrition in cystic fibrosis: a review.The development of diabetes among Danish cystic fibrosis patients over the last two decades.Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why.CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.How do adults with cystic fibrosis cope following a diagnosis of diabetes?[Cystic fibrosis-related diabetes: a frequent co-morbidity].Conventional measures underestimate glycaemia in cystic fibrosis patients.Mechanisms of glucose intolerance in cystic fibrosis.Characteristics of adults with and without cystic fibrosis-related diabetes.Pharmacological management of cystic fibrosis related diabetes.A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema.
P2860
Q26830633-A3E4506D-FFD5-4BED-AE05-B56D9B2717AFQ28067394-CD9CEA7B-27EA-4D1D-8454-1A73FAAAE7AFQ28661248-57C49AEC-6506-41BB-9050-0840F7892482Q33247492-7238D965-CB62-4A91-B274-05F730045E80Q33602084-4CCE0D56-E5B6-40F8-87C7-6C251A9F6A26Q33644742-0ABDD033-45DE-41FE-8986-6A957171DC2EQ34351928-4AB946DD-62F7-438A-8EFC-2105EB2148E5Q35087420-034635D1-FED5-437C-A937-0CAA9BA50978Q35102129-7478D346-AE9A-44B7-B009-5401905416BFQ35118399-0996CDAF-F86C-4227-B67B-A4AFA64FFBAAQ35145129-09AE8CD5-49E2-40EE-8DAA-792BC1A5C0A2Q35277941-6B95A88D-2B5F-478C-B461-388272058C53Q35284521-708DFB3A-7269-4C82-92A6-9172622F06A7Q36842031-35150B20-F960-43EF-8196-1E79BA9C95D9Q36882061-8D57DCFE-A9EF-43DE-BCBA-0169861D04A3Q37171973-3166443A-9844-4E01-8331-FCA3AB98A4E0Q37176856-10261EF2-D908-47C1-AAED-85637E746438Q37193199-82EEFD8F-19C5-4863-95DA-58AD226592E5Q37203256-214A7D17-794F-4326-8329-9DA98C939BB0Q37259700-A387BDE5-2C60-4F5B-8E49-DFCED2591BB5Q37470271-34C71E1D-47FD-43FA-AEC7-4C7F73C99DA4Q37483419-0DAA8613-8051-4905-BAE2-A59701B61238Q37576093-72634883-A34B-422B-AA5D-7143CCD5B7D1Q37583973-6A68CAF0-9F7E-4A27-B6A0-A9801FD3F950Q37597457-84B2C815-76F0-44D8-8878-A67B71BD76ABQ37760427-DEA97715-DCBC-439F-A635-08B438D1A9EFQ37882620-B6D5D6BE-3BEF-4557-ADF8-6988C75B915EQ38156392-DD4C0753-564A-4BF9-BDB0-08E246CE9CF0Q38217187-C234F885-E8B1-46C1-BB4F-A7EEF48E39ECQ38416187-FC52F91E-D37E-459A-9590-4CF9686C0224Q38656600-C2C53BF0-E6D3-4B85-9C2D-47878150F628Q38857042-16BAA8BC-D0A7-4848-A465-13A4BE6FEF5CQ43538692-647B0A27-24D8-4EEB-9001-C529D59B930AQ43749886-6B3A3F5B-7367-417A-B944-F475A8C6C1CBQ43957797-80AC724F-D3FD-433C-9568-4FDDA24E1013Q44946386-F08B367D-C96F-4F6B-87D0-CC2BF14EEC4DQ45963284-4877B414-4205-4521-9FCB-F7FD1F72999FQ46987561-3DFF0C9F-833C-4EBB-8A3A-231736327E1CQ47266208-F4D05320-27BA-423A-A0D3-D397607BCBAFQ48935663-7A577D45-BBCA-4B9A-8982-8774FCE6264C
P2860
Glucose tolerance in patients with cystic fibrosis: five year prospective study.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Glucose tolerance in patients with cystic fibrosis: five year prospective study.
@en
type
label
Glucose tolerance in patients with cystic fibrosis: five year prospective study.
@en
prefLabel
Glucose tolerance in patients with cystic fibrosis: five year prospective study.
@en
P2093
P2860
P356
P1433
P1476
Glucose tolerance in patients with cystic fibrosis: five year prospective study.
@en
P2093
P2860
P304
P356
10.1136/BMJ.311.7006.655
P407
P577
1995-09-01T00:00:00Z